Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 8:9:897987.
doi: 10.3389/fmed.2022.897987. eCollection 2022.

The Burden of Living With Cutaneous Lupus Erythematosus

Affiliations
Review

The Burden of Living With Cutaneous Lupus Erythematosus

Cristina Drenkard et al. Front Med (Lausanne). .

Abstract

Cutaneous lupus erythematosus (CLE) is a group of heterogeneous autoimmune disorders primarily affecting the skin. Patients with these conditions are mostly young women when they become sick and often suffer from recurrent skin symptoms or longstanding changes in their physical appearance. CLE disorders lead to different levels of morbidity and can impact profoundly patients' quality of life, particularly in the psychological and social health domains. This review provides a summary of recent research investigating the psychosocial burden of living with CLE and the intersect amongst the disease characteristics, patient factors, and social determinants of health. Furthermore, this review provides insight into patient care and research needs that remain unmet to improve the quality of life of patients living with CLE.

Keywords: cutaneous lupus erythematosus (CLE); disease burden; psychosocial impact; quality of life; racial minorities.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Okon LG, Werth VP. Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Clin Rheumatol. (2013) 27:391–404. 10.1016/j.berh.2013.07.008 - DOI - PMC - PubMed
    1. Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. (1981) 4:471–5. 10.1016/S0190-9622(81)80261-7 - DOI - PubMed
    1. Werth VP. Clinical manifestations of cutaneous lupus erythematosus. Autoimmun Rev. (2005) 4:296–302. 10.1016/j.autrev.2005.01.003 - DOI - PubMed
    1. Obermoser G, Sontheimer RD, Zelger B. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus. (2010) 19:1050–70. 10.1177/0961203310370048 - DOI - PubMed
    1. Jarukitsopa S, Hoganson DD, Crowson CS, Sokumbi O, Davis MD, Michet CJ, et al. . Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly White population in the United States. Arthritis Care Res. (2015) 67:817–28. 10.1002/acr.22502 - DOI - PMC - PubMed

LinkOut - more resources